

Developer of antibodies and protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases. The company is primarily focused on developing a biotherapeutics pipeline through strategic collaborations and internal research programs. It also combines proprietary molecular modeling and simulation software with high-performance computing to create an environment for in silicon experimentation and predictive protein optimization.